99

Breakthroughs
Sub Categories on Breakthroughs
Latest Articles
Study suggests statins could help fight gum disease

Study suggests statins could help fight gum disease

byAmerican Society for Biochemistry and Molecular BiologyCredit: Pixabay/CC0 Public DomainCould taking statins benefit your mouth in addition to your arteries? A new study conducted in cell cult

Study suggests statins could help fight gum disease

byAmerican Society for Biochemistry and Molecular BiologyCredit: Pixabay/CC0 Public DomainCould taking statins benefit your mouth in addition to your arteries? A new study conducted in cell cult
World-first human trial finds arthritis drug can suppress progression of type 1 diabetes

World-first human trial finds arthritis drug can suppress progression of type 1 diabetes

DECEMBER 6, 2023bySt Vincent's Institute of Medical ResearchCredit: CC0 Public DomainResearchers at St Vincent's Institute of Medical Research (SVI) in Melbourne have shown that a common

World-first human trial finds arthritis drug can suppress progression of type 1 diabetes

DECEMBER 6, 2023bySt Vincent's Institute of Medical ResearchCredit: CC0 Public DomainResearchers at St Vincent's Institute of Medical Research (SVI) in Melbourne have shown that a common
A potential method for interrupting the misfolding of tau protein that underlies neurodegenerative disease

A potential method for interrupting the misfolding of tau protein that underlies neurodegenerative disease

by Sonia Fernandez,University of California - Santa BarbaraInvestigation of the effect of VHH Z70 nanobody on jR2R3 P301L-induced tau fibrillization in cells. Credit:Proceedings of the Nat

A potential method for interrupting the misfolding of tau protein that underlies neurodegenerative disease

by Sonia Fernandez,University of California - Santa BarbaraInvestigation of the effect of VHH Z70 nanobody on jR2R3 P301L-induced tau fibrillization in cells. Credit:Proceedings of the Nat
A step closer to treatment for severe bacterial infections and sepsis

A step closer to treatment for severe bacterial infections and sepsis

JANUARY 10, 2024byLund UniversityThe illustration depicts how the researchers' peptide treatment (pink) binds to both receptors that can detect bacterial substances (green) and to bacterial

A step closer to treatment for severe bacterial infections and sepsis

JANUARY 10, 2024byLund UniversityThe illustration depicts how the researchers' peptide treatment (pink) binds to both receptors that can detect bacterial substances (green) and to bacterial
New guidelines for reporting clinical trials of biofield therapies released

New guidelines for reporting clinical trials of biofield therapies released

byMary Ann Liebert, IncCredit: Unsplash/CC0 Public DomainNewguidelinesfor reporting clinical trials of biofield therapies are presented in theJournal of Integrative and Complem

New guidelines for reporting clinical trials of biofield therapies released

byMary Ann Liebert, IncCredit: Unsplash/CC0 Public DomainNewguidelinesfor reporting clinical trials of biofield therapies are presented in theJournal of Integrative and Complem
Trials shows bimekizumab response durable at four years for moderate-to-severe psoriasis

Trials shows bimekizumab response durable at four years for moderate-to-severe psoriasis

by Tina BrownPatients with psoriasis treated with bimekizumab rapidly achieve high levels of clinical and health-related quality-of-life responses that are durable at four years, according to research

Trials shows bimekizumab response durable at four years for moderate-to-severe psoriasis

by Tina BrownPatients with psoriasis treated with bimekizumab rapidly achieve high levels of clinical and health-related quality-of-life responses that are durable at four years, according to research
Researchers discover a potential cause of Parkinson's disease

Researchers discover a potential cause of Parkinson's disease

MAY 5, 2023byUniversity of HelsinkiAggregation of alpha-synuclein in a nerve cell. Credit: Timo Myöhänen research groupThere are currently 8 million patients with Parkinson's disease in the

Researchers discover a potential cause of Parkinson's disease

MAY 5, 2023byUniversity of HelsinkiAggregation of alpha-synuclein in a nerve cell. Credit: Timo Myöhänen research groupThere are currently 8 million patients with Parkinson's disease in the
Atezolizumab addition to chemotherapy after surgery does not improve survival for triple negative breast cancer: Study

Atezolizumab addition to chemotherapy after surgery does not improve survival for triple negative breast cancer: Study

by European Organisation for Research and Treatment of CancerCredit: Unsplash/CC0 Public DomainPatients with triple-negative breast cancer do not benefit from the addition of atezolizumab to their pos

Atezolizumab addition to chemotherapy after surgery does not improve survival for triple negative breast cancer: Study

by European Organisation for Research and Treatment of CancerCredit: Unsplash/CC0 Public DomainPatients with triple-negative breast cancer do not benefit from the addition of atezolizumab to their pos
New web portal empowers drug discovery, systems-level analysis of critical kinase-substrate interactions

New web portal empowers drug discovery, systems-level analysis of critical kinase-substrate interactions

byThe Mount Sinai HospitalKiNet functionalities. Credit:npj Systems Biology and Applications(2024). DOI: 10.1038/s41540-024-00442-5Researchers from the Icahn School of Medicine at Mo

New web portal empowers drug discovery, systems-level analysis of critical kinase-substrate interactions

byThe Mount Sinai HospitalKiNet functionalities. Credit:npj Systems Biology and Applications(2024). DOI: 10.1038/s41540-024-00442-5Researchers from the Icahn School of Medicine at Mo
How to make mRNA therapeutics safe from the start

How to make mRNA therapeutics safe from the start

FEBRUARY 28, 2024by Cynthia McCormick Hibbert,Northeastern UniversityScientists eager to harness mRNA technology to fight cancer and more need to find ways to test early for safety, Northeastern

How to make mRNA therapeutics safe from the start

FEBRUARY 28, 2024by Cynthia McCormick Hibbert,Northeastern UniversityScientists eager to harness mRNA technology to fight cancer and more need to find ways to test early for safety, Northeastern